<VariationArchive VariationID="239724" VariationName="NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del)" VariationType="Deletion" Accession="VCV000239724" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="240277" VariationID="239724">
      <GeneList>
        <Gene Symbol="RECQL4" FullName="RecQ like helicase 4" GeneID="9401" HGNC_ID="HGNC:9949" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144511288" stop="144517833" display_start="144511288" display_stop="144517833" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145736666" stop="145743209" display_start="145736666" display_stop="145743209" Strand="-" />
          </Location>
          <OMIM>603780</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del)</Name>
      <CanonicalSPDI>NC_000008.11:144513260:CGCCCGGCCCG:CG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144513261" stop="144513269" display_start="144513261" display_stop="144513269" variantLength="9" positionVCF="144513260" referenceAlleleVCF="ACGCCCGGCC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145738644" stop="145738652" display_start="145738644" display_stop="145738652" variantLength="9" positionVCF="145738643" referenceAlleleVCF="ACGCCCGGCC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_277" sequenceAccession="LRG_277">
            <Expression>LRG_277:g.9558_9566del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_277t1" sequenceAccession="LRG_277t1">
            <Expression>LRG_277t1:c.2412_2420del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_277p1" sequenceAccession="LRG_277p1" change="p.Ala805_Arg807del">
            <Expression>LRG_277p1:p.Ala805_Arg807del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.145738646_145738654del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.145738646_145738654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.144513263_144513271del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.144513263_144513271del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016430.2" sequenceAccession="NG_016430" sequenceVersion="2" change="g.9558_9566del">
            <Expression>NG_016430.2:g.9558_9566del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033083.1" sequenceAccession="NG_033083" sequenceVersion="1" change="g.298_306del">
            <Expression>NG_033083.1:g.298_306del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004260.4" sequenceAccession="NM_004260" sequenceVersion="4" change="c.2412_2420del" MANESelect="true">
            <Expression>NM_004260.4:c.2412_2420del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004251.4" sequenceAccession="NP_004251" sequenceVersion="4" change="p.Ala805_Arg807del">
            <Expression>NP_004251.4:p.Ala805_Arg807del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004260.3" sequenceAccession="NM_004260" sequenceVersion="3" change="c.2412_2420delGGCCGGGCG">
            <Expression>NM_004260.3:c.2412_2420delGGCCGGGCG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4948299" DB="ClinGen" />
        <XRef Type="rs" ID="766312203" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del) AND Baller-Gerold syndrome" Accession="RCV000234695" Version="10">
        <ClassifiedConditionList TraitSetID="1682">
          <ClassifiedCondition DB="MedGen" ID="C0265308">Baller-Gerold syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del) AND not provided" Accession="RCV001731539" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del) AND Rothmund-Thomson syndrome type 2" Accession="RCV002243905" Version="2">
        <ClassifiedConditionList TraitSetID="51243">
          <ClassifiedCondition DB="MedGen" ID="C5203410">Rothmund-Thomson syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.2412_2420del (p.Ala805_Arg807del) AND multiple conditions" Accession="RCV002500783" Version="1">
        <ClassifiedConditionList TraitSetID="52003">
          <ClassifiedCondition DB="MedGen" ID="C0265308">Baller-Gerold syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1849453">Rapadilino syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5203410">Rothmund-Thomson syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29642415</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31604778</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52003" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis radial aplasia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis with radial defects</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Baller-Gerold syndrome</ElementValue>
                <XRef ID="Craniosynostosis+Radial+Aplasia+Syndrome/1995" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009039" DB="MONDO" />
                <XRef ID="77608001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BGS</ElementValue>
                <XRef Type="MIM" ID="218600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1602" />
                <XRef ID="1602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Baller-Gerold syndrome (BGS) can be suspected at birth in an infant with craniosynostosis and upper limb abnormality. The coronal suture is most commonly affected; the metopic, lambdoid, and sagittal sutures may also be involved alone or in combination. Upper limb abnormality can include a combination of thumb hypo- or aplasia and radial hypo- or aplasia and may be asymmetric. Malformation or absence of carpal or metacarpal bones has also been described. Skin lesions may appear anytime within the first few years after birth, typically beginning with erythema of the face and extremities and evolving into poikiloderma. Slow growth is apparent in infancy with eventual height and length typically at 4 SD below the mean.</Attribute>
                <XRef ID="NBK1204" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301383</ID>
                <ID Source="BookShelf">NBK1204</ID>
              </Citation>
              <XRef ID="1225" DB="Orphanet" />
              <XRef ID="C0265308" DB="MedGen" />
              <XRef ID="MONDO:0009039" DB="MONDO" />
              <XRef Type="MIM" ID="218600" DB="OMIM" />
            </Trait>
            <Trait ID="43045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rothmund-Thomson syndrome type 2</ElementValue>
                <XRef ID="MONDO:0016369" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTS2</ElementValue>
                <XRef Type="MIM" ID="268400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; juvenile cataracts; and an increased risk for cancer, especially osteosarcoma. A variety of benign and malignant hematologic abnormalities have been reported in affected individuals. The rash of RTS typically develops between ages three and six months (occasionally as late as age two years) as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively known as poikiloderma) that persist throughout life. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities can include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</Attribute>
                <XRef ID="NBK1237" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17135" />
                <XRef ID="17135" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301415</ID>
                <ID Source="BookShelf">NBK1237</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="221016" DB="Orphanet" />
              <XRef ID="C5203410" DB="MedGen" />
              <XRef ID="MONDO:0016369" DB="MONDO" />
              <XRef Type="MIM" ID="268400" DB="OMIM" />
            </Trait>
            <Trait ID="3578" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rapadilino syndrome</ElementValue>
                <XRef ID="Rapadilino+syndrome/6152" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009955" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Radial and patellar aplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Radial and patellar hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Absent thumbs, dislocated joints, long face with narrow palpebral fissures, long slender nose, arched palate</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4637" />
                <XRef ID="4637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3021" DB="Orphanet" />
              <XRef ID="C1849453" DB="MedGen" />
              <XRef ID="MONDO:0009955" DB="MONDO" />
              <XRef Type="MIM" ID="266280" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1682" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis radial aplasia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis with radial defects</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Baller-Gerold syndrome</ElementValue>
                <XRef ID="Craniosynostosis+Radial+Aplasia+Syndrome/1995" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009039" DB="MONDO" />
                <XRef ID="77608001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BGS</ElementValue>
                <XRef Type="MIM" ID="218600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1602" />
                <XRef ID="1602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Baller-Gerold syndrome (BGS) can be suspected at birth in an infant with craniosynostosis and upper limb abnormality. The coronal suture is most commonly affected; the metopic, lambdoid, and sagittal sutures may also be involved alone or in combination. Upper limb abnormality can include a combination of thumb hypo- or aplasia and radial hypo- or aplasia and may be asymmetric. Malformation or absence of carpal or metacarpal bones has also been described. Skin lesions may appear anytime within the first few years after birth, typically beginning with erythema of the face and extremities and evolving into poikiloderma. Slow growth is apparent in infancy with eventual height and length typically at 4 SD below the mean.</Attribute>
                <XRef ID="NBK1204" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301383</ID>
                <ID Source="BookShelf">NBK1204</ID>
              </Citation>
              <XRef ID="1225" DB="Orphanet" />
              <XRef ID="C0265308" DB="MedGen" />
              <XRef ID="MONDO:0009039" DB="MONDO" />
              <XRef Type="MIM" ID="218600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="51243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rothmund-Thomson syndrome type 2</ElementValue>
                <XRef ID="MONDO:0016369" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTS2</ElementValue>
                <XRef Type="MIM" ID="268400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; juvenile cataracts; and an increased risk for cancer, especially osteosarcoma. A variety of benign and malignant hematologic abnormalities have been reported in affected individuals. The rash of RTS typically develops between ages three and six months (occasionally as late as age two years) as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively known as poikiloderma) that persist throughout life. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities can include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</Attribute>
                <XRef ID="NBK1237" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17135" />
                <XRef ID="17135" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301415</ID>
                <ID Source="BookShelf">NBK1237</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="221016" DB="Orphanet" />
              <XRef ID="C5203410" DB="MedGen" />
              <XRef ID="MONDO:0016369" DB="MONDO" />
              <XRef Type="MIM" ID="268400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4924213" SubmissionDate="2022-05-11" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="NM_004260.4:c.2412_2420del|OMIM:268400" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512442" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PS4 supporting, PM2 moderate, PM3 moderate, PM4 moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.4:c.2412_2420del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11461911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5462512" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_004260.4:c.2412_2420del|OMIM:218600;266280;268400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002813956" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.4:c.2412_2420del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266280" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3877308" SubmissionDate="2021-10-22" DateLastUpdated="2023-03-04" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="GDXSV:185596" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001982112" DateUpdated="2023-03-04" DateCreated="2021-10-30" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Identified in unrelated patients with RECQL4-related phenotype referred for genetic testing at GeneDx and in published literature (Colombo et al., 2018); In-frame deletion of 3 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29642415, 31604778)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:3382917</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.2412_2420del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_62_20211022152658</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="543448" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="335548|MedGen:C0265308" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000288218" DateUpdated="2024-02-14" DateCreated="2016-07-01" Type="SCV" Version="10" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29642415</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31604778</ID>
          </Citation>
          <Comment>This variant, c.2412_2420del, results in the deletion of 3 amino acid(s) of the RECQL4 protein (p.Ala805_Arg807del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs766312203, gnomAD 0.06%). This variant has been observed in individual(s) with Rothmund-Thomson syndrome (PMID: 29642415, 31604778; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 239724). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.145738644_145738652del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265308" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5462512" TraitType="Disease" MappingType="XRef" MappingValue="266280" MappingRef="OMIM">
        <MedGen CUI="C1849453" Name="Rapadilino syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3877308" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462512" TraitType="Disease" MappingType="XRef" MappingValue="268400" MappingRef="OMIM">
        <MedGen CUI="C5203410" Name="Rothmund-Thomson syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462512" TraitType="Disease" MappingType="XRef" MappingValue="218600" MappingRef="OMIM">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924213" TraitType="Disease" MappingType="XRef" MappingValue="268400" MappingRef="OMIM">
        <MedGen CUI="C5203410" Name="Rothmund-Thomson syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="543448" TraitType="Disease" MappingType="XRef" MappingValue="C0265308" MappingRef="MedGen">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

